Community/Retail

Officials with the FDA have approved benralizumab (Fasenra, AstraZeneca) for the add-on maintenance treatment of patients with severe eosinophilic asthma aged 12 years and older.

The sensor that is used along with aripiprazole was first cleared for use by the FDA in 2012; however, the approval of the pill and the sensor together represents a first for the FDA.

A low sodium-DASH diet combination lowers blood pressure (BP) in adults with hypertension, according to the results of preliminary research at the American Heart Association’s (AHA) Scientific Sessions 2017.

Officials with the FDA have approved an adjuvanted hepatitis B vaccine, recombinant [Heplisav-B, Dynavax] for the prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older.